NYSE Euronext (NYX) experienced record trading activity on its U.S. cash equities exchanges and all of its derivatives operations for the month of September 2008. In addition, NYSE Euronext’s markets added 60 new corporate listings and 75 Exchange Traded Products.
Global Cash Equities:
- NYSE Euronext’s four European cash equities exchanges traded an average daily volume of 1.8 million transactions1 in September 2008, up 44.4% compared to September 2007. Based on total monthly cash volume of 40.7 million transactions, September was the second-busiest month ever for trading in Euronext’s cash equity markets. Pack Epsilon, a dedicated pricing package for high frequency traders launched on July 1, accounted for approximately 30% of total European equity volumes in September.
- NYSE Euronext’s U.S. cash equities exchanges, NYSE and NYSE Arca, reported average daily volume of 4.4 billion shares handled2 during September, an increase of 71.5% versus the same period last year. NYSE Euronext’s U.S. cash equities exchanges experienced their most active month, week and days in history, including an all-time NYSE Group trading record of 7.3 billion shares handled on Sept. 18. NYSE Group's matched market share increased in NYSE-listed, NYSE Arca & Amex-listed and Nasdaq-listed shares in September 2008 versus August 2008.
Global Derivatives:
- NYSE Euronext’s derivatives trading operations on Liffe traded average daily volume of 4.8 million contracts in September; or 3.8 million contracts excluding Bclear. Bclear processed an average daily volume of 1.0 million equity derivative contracts, an increase of 36.1% versus September 2007. Based on total monthly volume for all European derivative operations, Liffe experienced its busiest month ever, trading a total of 106 million futures and options contracts, up 10.3% from September last year. Liffe also registered a record volume day on Sept. 16 with over 9.9 million contracts transacted.
- NYSE Arca Options traded an average daily volume of 2.0 million contracts during the month, an increase of 65.7% compared to September 2007. In addition, NYSE Arca Options’ market share increased in September 2008 versus August 2008. For equity options trading in the SEC Penny Pilot program, NYSE Arca Options executed 13.6% of all eligible issues in September 2008.
Global Listings:
- In September, NYSE Euronext’s markets added 60 new corporate listings: 56 in the U.S. and four in Europe.
- The NYSE listed two structured products, while NYSE Arca listed 49 Exchange Traded Products (ETPs) and European markets listed 26 ETPs, excluding the turnover in warrants and certificates, bringing the total number of Exchange Traded Products listed on all NYSE Euronext markets to 754.
Please click here for the Monthly Transaction Activity Data Table.
About NYSE Euronext
NYSE Euronext (NYX) operates the world’s leading and most liquid exchange group, and seeks to provide the highest levels of quality, customer choice and innovation. Its family of exchanges, located in six countries, includes the New York Stock Exchange, the world's largest cash equities market; Euronext, the Eurozone's largest cash equities market; Liffe, Europe's leading derivatives exchange by value of trading; NYSE Liffe, the company’s U.S. futures business and NYSE Arca Options, one of the fastest growing U.S. options trading platforms. NYSE Euronext offers a diverse array of financial products and services for issuers, investors and financial institutions in cash equities, options, futures and derivatives, ETFs, bonds, market data, and commercial technology solutions. As the world’s largest exchange group by number of listings and market capitalization, NYSE Euronext is home to more than 6,500 listed issues (as of Oct. 1, 2008) with total global market capitalization more than four times that of any other exchange group. The average daily trading value of NYSE Euronext's equity exchanges represent more than one-third of the world's cash equities trading. NYSE Euronext is part of the S&P 500 index and the only exchange operator in the S&P 100 index. For more information and free real-time stock prices for all NYSE-listed securities, please visit www.nyx.com.
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext’s plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext’s results to differ materially from current expectations include, but are not limited to: NYSE Euronext’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext’s reference document for 2007 ("document de référence") filed with the French Autorité des Marchés Financiers (Registered on May 15, 2008 under No. R. 08-054), 2007 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.
1 Euronext equities transactions count each buy and sell order as separate transactions, NYSE Group equities transactions count buy and sell orders together as a single transaction. All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction.
2 Handled shares represent the total number of shares of equity securities internally matched on the NYSE Group's exchanges or routed to and executed at an external market center.
| NYSE Euronext | ||||||||||||||||
| Monthly Volume Summary - Cash Products | ||||||||||||||||
| Average Daily Volume | Total Volume | Total Volume | ||||||||||||||
| (Unaudited) | Sep-08 | Sep-07 | % Chg | Sep-08 | Sep-07 | % Chg | YTD 2008 | % Chg vs. YTD 2007 | ||||||||
| Number of Trading Days - European Markets | 22 | 20 | 22 | 20 | 192 | |||||||||||
| Number of Trading Days - U.S. Markets | 21 | 19 | 21 | 19 | 189 | |||||||||||
| European Cash Products (trades in thousands) | 1,848 | 1,280 | 44.4% | 40,661 | 25,597 | 58.8% | 292,870 | 24.2% | ||||||||
| Equities | 1,787 | 1,231 | 45.1% | 39,316 | 24,628 | 59.6% | 282,904 | 25.2% | ||||||||
| Exchange-Traded Funds | 11 | 6 | 79.0% | 232 | 118 | 96.9% | 1,496 | 37.3% | ||||||||
| Structured Products | 46 | 37 | 22.7% | 1,003 | 743 | 35.0% | 7,470 | -1.9% | ||||||||
| Bonds | 5 | 5 | -7.9% | 110 | 108 | 1.3% | 1,000 | -20.3% | ||||||||
| U.S. Cash Products (shares in millions) 2 | 4,366 | 2,545 | 71.5% | 91,684 | 48,355 | 89.6% | 632,836 | 17.0% | ||||||||
| NYSE Listed Issues 1 | ||||||||||||||||
| NYSE Group Handled Volume 2 | 3,179 | 2,006 | 58.5% | 66,768 | 38,123 | 75.1% | 469,306 | 11.9% | ||||||||
| NYSE Group Matched Volume 3 | 2,872 | 1,808 | 58.8% | 60,308 | 34,354 | 75.5% | 423,333 | 8.5% | ||||||||
| NYSE Group TRF Volume 4 | 517 | 148 | 250.2% | 10,853 | 2,804 | 287.1% | 55,983 | 729.0% | ||||||||
| Total NYSE Listed Consolidated Volume | 6,812 | 3,224 | 111.3% | 143,061 | 61,260 | 133.5% | 905,642 | 45.7% | ||||||||
| NYSE Group Share of Total Consolidated Volume | ||||||||||||||||
| Handled Volume 2 | 46.7% | 62.2% | 46.7% | 62.2% | 51.8% | |||||||||||
| Matched Volume 3 | 42.2% | 56.1% | 42.2% | 56.1% | 46.7% | |||||||||||
| TRF Volume 4 | 7.6% | 4.6% | 7.6% | 4.6% | 6.2% | |||||||||||
| NYSE Arca & Amex Listed Issues | ||||||||||||||||
| NYSE Group Handled Volume 2 | 669 | 200 | 235.2% | 14,056 | 3,794 | 270.5% | 77,835 | 104.9% | ||||||||
| NYSE Group Matched Volume 3 | 586 | 170 | 245.9% | 12,316 | 3,221 | 282.4% | 67,670 | 106.2% | ||||||||
| NYSE Group TRF Volume 4 | 286 | 34 | 744.5% | 6,007 | 644 | 833.4% | 27,179 | 912.6% | ||||||||
| Total NYSE Arca & Amex Listed Consolidated Volume | 2,037 | 572 | 256.3% | 42,783 | 10,865 | 293.8% | 237,723 | 137.4% | ||||||||
| NYSE Group Share of Total Consolidated Volume | ||||||||||||||||
| Handled Volume 2 | 32.9% | 34.9% | 32.9% | 34.9% | 32.7% | |||||||||||
| Matched Volume 3 | 28.8% | 29.6% | 28.8% | 29.6% | 28.5% | |||||||||||
| TRF Volume 4 | 14.0% | 5.9% | 14.0% | 5.9% | 11.4% | |||||||||||
| Nasdaq Listed Issues | ||||||||||||||||
| NYSE Group Handled Volume 2 | 517 | 339 | 52.6% | 10,860 | 6,438 | 68.7% | 85,696 | 2.5% | ||||||||
| NYSE Group Matched Volume 3 | 443 | 271 | 63.5% | 9,294 | 5,142 | 80.7% | 71,772 | 5.1% | ||||||||
| NYSE Group TRF Volume 4 | 289 | 140 | 105.9% | 6,066 | 2,666 | 127.5% | 41,536 | 162.3% | ||||||||
| Total Nasdaq Listed Consolidated Volume | 2,531 | 1,925 | 31.5% | 53,157 | 36,574 | 45.3% | 428,240 | 5.4% | ||||||||
NYSE Group Share of Total Consolidated Volume | ||||||||||||||||
| Handled Volume 2 | 20.4% | 17.6% | 20.4% | 17.6% | 20.0% | |||||||||||
| Matched Volume 3 | 17.5% | 14.1% | 17.5% | 14.1% | 16.8% | |||||||||||
| TRF Volume 4 | 11.4% | 7.3% | 11.4% | 7.3% | 9.7% | |||||||||||
| Exchange-Traded Funds 1,5 | ||||||||||||||||
| NYSE Group Handled Volume 2 | 708 | 264 | 167.9% | 14,862 | 5,018 | 196.1% | 82,759 | 62.1% | ||||||||
| NYSE Group Matched Volume 3 | 623 | 233 | 167.3% | 13,075 | 4,426 | 195.4% | 72,391 | 58.8% | ||||||||
| NYSE Group TRF Volume 4 | 325 | 46 | 602.7% | 6,831 | 879 | 676.7% | 30,138 | 678.1% | ||||||||
| Total ETF Consolidated Volume | 2,171 | 689 | 215.0% | 45,600 | 13,096 | 248.2% | 250,137 | 107.6% | ||||||||
| NYSE Group Share of Total Consolidated Volume | ||||||||||||||||
| Handled Volume 2 | 32.6% | 38.3% | 32.6% | 38.3% | 33.1% | |||||||||||
| Matched Volume 3 | 28.7% | 33.8% | 28.7% | 33.8% | 28.9% | |||||||||||
| TRF Volume 4 | 15.0% | 6.7% | 15.0% | 6.7% | 12.0% | |||||||||||
| NYSE Euronext | ||||||||||||||||
| Monthly Volume Summary - Derivatives Products | ||||||||||||||||
| Average Daily Volume | Total Volume | Total Volume | ||||||||||||||
| (Unaudited; contracts in thousands) | Sep- 08 | Sep- 07 | % Chg | Sep- 08 | Sep- 07 | % Chg | YTD 2008 | % Chg vs. YTD 2007 | ||||||||
| Number of Trading Days - European Markets | 22 | 20 | 22 | 20 | 192 | |||||||||||
| Number of Trading Days - U.S. Markets | 21 | 19 | 21 | 19 | 189 | |||||||||||
| European Derivatives Products | 4,800 | 4,787 | 0.3% | 105,605 | 95,739 | 10.3% | 813,622 | 12.3% | ||||||||
| Total Interest Rate Products 6 | 2,274 | 2,691 | -15.5% | 50,021 | 53,822 | -7.1% | 443,738 | 11.2% | ||||||||
| Short Term Interest Rate Products | 2,165 | 2,585 | -16.3% | 47,631 | 51,706 | -7.9% | 423,361 | 12.4% | ||||||||
| Medium and Long Term Interest Rate Products | 109 | 106 | 2.7% | 2,390 | 2,116 | 13.0% | 20,377 | -8.4% | ||||||||
| Total Equity Products 7 | 2,477 | 2,040 | 21.4% | 54,483 | 40,796 | 33.5% | 359,465 | 13.7% | ||||||||
| Individual Equity Products | 1,614 | 1,365 | 18.2% | 35,499 | 27,302 | 30.0% | 234,432 | 17.5% | ||||||||
| Equity Index Products | 863 | 675 | 27.9% | 18,984 | 13,495 | 40.7% | 125,033 | 7.2% | ||||||||
| of which Bclear | 995 | 731 | 36.1% | 21,884 | 14,619 | 49.7% | 145,208 | 61.7% | ||||||||
| Individual Equity Products | 858 | 618 | 38.8% | 18,875 | 12,358 | 52.7% | 124,880 | 65.7% | ||||||||
| Equity Index Products | 137 | 113 | 20.9% | 3,008 | 2,261 | 33.0% | 20,328 | 41.0% | ||||||||
| Commodity Products | 50 | 56 | -10.7% | 1,101 | 1,121 | -1.8% | 10,418 | 11.8% | ||||||||
| U.S. Derivatives Products - Equity Options 8 | ||||||||||||||||
| NYSE Arca Options Contracts | 2,007 | 1,211 | 65.7% | 42,140 | 23,010 | 83.1% | 328,292 | 48.9% | ||||||||
Total Con- solidated Options Contracts | 16,252 | 9,622 | 68.9% | 341,302 | 182,814 | 86.7% | 2,521,133 | 38.3% | ||||||||
| NYSE Group Share of Total | 12.3% | 12.6% | 12.3% | 12.6% | 13.0% | 0.9% | ||||||||||
| 1 | Includes all volume executed in NYSE Group crossing sessions. | |
| 2 | Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots. | |
| 3 | Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. | |
| 4 | Represents NYSE's volume in FINRA/NYSE Trade Reporting Facility (TRF). | |
| 5 | Data included in previously identified categories. | |
| 6 | Data includes currency products. | |
7 | Includes all trading activities for Bclear, Euronext.liffe's clearing service for wholesale equity derivatives. | |
| 8 | Includes trading in U.S. equity options contracts, not equity-index options. | |
| Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. | ||
| All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells. |
Contacts:
Investor Relations:
+1 212-656-5700 (New York)
+33-1-49-27-58-60
(Paris)
or
Media:
+31-20-550-4488 (Amsterdam),
+32-2-509-1392 (Brussels)
+351-217-900-029 (Lisbon),
+44-20-7379-2789 (London)
+1 212-656-2411 (New York),
+33-1-49-27-11-33 (Paris)
